CS212269B2 - Method of preparation of the biocompatible fibres from the polymeres - Google Patents
Method of preparation of the biocompatible fibres from the polymeres Download PDFInfo
- Publication number
- CS212269B2 CS212269B2 CS781720A CS172078A CS212269B2 CS 212269 B2 CS212269 B2 CS 212269B2 CS 781720 A CS781720 A CS 781720A CS 172078 A CS172078 A CS 172078A CS 212269 B2 CS212269 B2 CS 212269B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- substances
- polymer
- biocompatible
- added
- polymer solution
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims description 22
- 238000002360 preparation method Methods 0.000 title claims description 7
- 239000000126 substance Substances 0.000 claims abstract description 27
- 239000003146 anticoagulant agent Substances 0.000 claims abstract description 9
- 229940127219 anticoagulant drug Drugs 0.000 claims abstract description 8
- 239000000835 fiber Substances 0.000 claims description 16
- 238000009987 spinning Methods 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 239000004814 polyurethane Substances 0.000 claims description 5
- 229920002635 polyurethane Polymers 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 239000000427 antigen Substances 0.000 claims description 4
- 102000036639 antigens Human genes 0.000 claims description 4
- 108091007433 antigens Proteins 0.000 claims description 4
- 230000001407 anti-thrombic effect Effects 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 claims description 3
- 239000002344 surface layer Substances 0.000 claims description 3
- NPFBJJBIDYIAJD-UHFFFAOYSA-N 2-(2-amino-1,3-oxazol-4-yl)ethanol Chemical compound NC1=NC(CCO)=CO1 NPFBJJBIDYIAJD-UHFFFAOYSA-N 0.000 claims description 2
- 238000004873 anchoring Methods 0.000 claims description 2
- 239000003705 antithrombocytic agent Substances 0.000 claims description 2
- 229920000249 biocompatible polymer Polymers 0.000 claims description 2
- DOBMPNYZJYQDGZ-UHFFFAOYSA-N dicoumarol Chemical compound C1=CC=CC2=C1OC(=O)C(CC=1C(OC3=CC=CC=C3C=1O)=O)=C2O DOBMPNYZJYQDGZ-UHFFFAOYSA-N 0.000 claims description 2
- 229960001912 dicoumarol Drugs 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 2
- 230000000702 anti-platelet effect Effects 0.000 abstract 1
- 229920000891 common polymer Polymers 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 23
- 210000001772 blood platelet Anatomy 0.000 description 20
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000000839 emulsion Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 229920002284 Cellulose triacetate Polymers 0.000 description 6
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000003191 femoral vein Anatomy 0.000 description 6
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 238000004220 aggregation Methods 0.000 description 5
- 230000002776 aggregation Effects 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- -1 2-hydroxyethylaminooxazol Chemical compound 0.000 description 2
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 2
- 241000238876 Acari Species 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000011886 postmortem examination Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 2
- 231100000216 vascular lesion Toxicity 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ACTKAGSPIFDCMF-UHFFFAOYSA-N 1,3-oxazol-2-amine Chemical compound NC1=NC=CO1 ACTKAGSPIFDCMF-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000032984 Intraoperative Complications Diseases 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- IUJDSEJGGMCXSG-UHFFFAOYSA-N Thiopental Chemical compound CCCC(C)C1(CC)C(=O)NC(=S)NC1=O IUJDSEJGGMCXSG-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical class ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 208000027276 Von Willebrand disease Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- MEGHWIAOTJPCHQ-UHFFFAOYSA-N ethenyl butanoate Chemical compound CCCC(=O)OC=C MEGHWIAOTJPCHQ-UHFFFAOYSA-N 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- ZGEYCCHDTIDZAE-UHFFFAOYSA-N glutamic acid 5-methyl ester Chemical compound COC(=O)CCC(N)C(O)=O ZGEYCCHDTIDZAE-UHFFFAOYSA-N 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940043200 pentothal Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940081330 tena Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/062—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
- A61L33/0041—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate characterised by the choice of an antithrombatic agent other than heparin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Dispersion Chemistry (AREA)
- Biotechnology (AREA)
- Manufacturing & Machinery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Textile Engineering (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT21482/77A IT1085524B (it) | 1977-03-22 | 1977-03-22 | Materiali e fibre porose biocompatibili in grado di inglobare sostanze di interesse biologico e metodi per il loro ottenimento |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS212269B2 true CS212269B2 (en) | 1982-03-26 |
Family
ID=11182479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS781720A CS212269B2 (en) | 1977-03-22 | 1978-03-17 | Method of preparation of the biocompatible fibres from the polymeres |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4353996A (de) |
| JP (1) | JPS53117281A (de) |
| AU (1) | AU516197B2 (de) |
| BE (1) | BE865192A (de) |
| CA (1) | CA1095409A (de) |
| CH (1) | CH633712A5 (de) |
| CS (1) | CS212269B2 (de) |
| DD (1) | DD138601A5 (de) |
| DE (1) | DE2812174C2 (de) |
| DK (1) | DK113478A (de) |
| FR (1) | FR2395029A1 (de) |
| GB (1) | GB1602163A (de) |
| HU (1) | HU179581B (de) |
| IL (1) | IL54215A (de) |
| IT (1) | IT1085524B (de) |
| LU (1) | LU79273A1 (de) |
| NL (1) | NL7803101A (de) |
| NO (1) | NO144008C (de) |
| SE (1) | SE436242B (de) |
| YU (1) | YU66678A (de) |
| ZA (1) | ZA781362B (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1095574B (it) * | 1978-04-12 | 1985-08-10 | Snam Progetti | Procedimento per la preparazione di materiali biocompatibili di natura poliammidica e manufatti cosi'ottenuti |
| IT1096208B (it) * | 1978-05-12 | 1985-08-26 | Snam Progetti | Composizione adatta alla riduzione del tenore di fenilalanina e metodo impiegante la stessa |
| IT1099996B (it) * | 1978-10-17 | 1985-09-28 | Anic Spa | Derivati del 4,5-difenil-ossazolo 2-ammino o 2-tio sostituiti e procedimento per il loro ottenimento |
| DE2920500A1 (de) * | 1979-05-21 | 1980-11-27 | Boehringer Sohn Ingelheim | Pharmazeutische zubereitung in form eines polyacrylatfilmes |
| JPS6076562A (ja) * | 1983-10-03 | 1985-05-01 | Sumitomo Electric Ind Ltd | 抗血栓性樹脂組成物 |
| FR2554349A1 (fr) * | 1983-11-08 | 1985-05-10 | Immunotech Sa | Procede d'obtention de materiaux biocompatibles, materiaux obtenus par ce procede et leurs applications |
| US4563485A (en) * | 1984-04-30 | 1986-01-07 | The Trustees Of Columbia University In The City Of New York | Injection-resistant materials and method of making same through use of nalidixic acid derivatives |
| US4581028A (en) * | 1984-04-30 | 1986-04-08 | The Trustees Of Columbia University In The City Of New York | Infection-resistant materials and method of making same through use of sulfonamides |
| GB2167665A (en) * | 1984-12-04 | 1986-06-04 | Univ Liverpool | Platelet aggregation inhibitor for use in polymeric surgical devices |
| US4612337A (en) * | 1985-05-30 | 1986-09-16 | The Trustees Of Columbia University In The City Of New York | Method for preparing infection-resistant materials |
| EP0214392B1 (de) * | 1985-07-02 | 1990-05-23 | Omni Medical Limited | Medizinisches Gerät, insbesondere Filter, Kanüle, Katheter oder Implantat |
| US4909799A (en) * | 1987-09-18 | 1990-03-20 | Olav Thulesius | Methods for preventing thrombosis; and surgical implant having reduced platelet deposition characteristics |
| AU7998091A (en) * | 1990-05-17 | 1991-12-10 | Harbor Medical Devices, Inc. | Medical device polymer |
| US5302393A (en) * | 1991-07-11 | 1994-04-12 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Method for inhibiting biological degradation of implantation polymeric material, inhibitor thereof and implantation polymeric material containing the inhibitor |
| DE4293170T1 (de) * | 1991-10-01 | 1993-11-18 | Otsuka Pharma Co Ltd | Antithromboseharz, Antithromboseröhrchen, Antithrombosefilm und Antithromboseüberzug |
| EP0568451B1 (de) * | 1992-04-28 | 1999-08-04 | Terumo Kabushiki Kaisha | Thermoplastische Polymerzusammensetzung und daraus hergestellte medizinische Vorrichtungen |
| DE4221665C1 (de) * | 1992-07-02 | 1993-08-12 | Rehau Ag + Co, 8673 Rehau, De | |
| FR2747591B1 (fr) * | 1996-04-19 | 1998-05-22 | Hospal Ind | Appareil medical pour le traitement extracorporel du sang ou du plasma et procedes de fabrication de cet appareil |
| US6221997B1 (en) | 1997-04-28 | 2001-04-24 | Kimberly Ann Woodhouse | Biodegradable polyurethanes |
| GB0113697D0 (en) * | 2001-06-06 | 2001-07-25 | Smith & Nephew | Fixation devices for tissue repair |
| US7056286B2 (en) | 2003-11-12 | 2006-06-06 | Adrian Ravenscroft | Medical device anchor and delivery system |
| WO2009152487A2 (en) * | 2008-06-13 | 2009-12-17 | Smith & Nephew, Inc. | Fixation devices for tissue repair |
| US9649211B2 (en) | 2009-11-04 | 2017-05-16 | Confluent Medical Technologies, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
| WO2011056981A2 (en) | 2009-11-04 | 2011-05-12 | Nitinol Devices And Components, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT241016B (de) * | 1962-12-14 | 1965-06-25 | Spofa Vereinigte Pharma Werke | Hochporöse Kollagen-Gewebe-Blutgefäßprothese und Verfahren zur Herstellung derselben |
| US3674901A (en) * | 1966-07-26 | 1972-07-04 | Nat Patent Dev Corp | Surgical sutures |
| IL32406A (en) * | 1968-06-26 | 1973-01-30 | Snam Progetti | Enzyme preparations comprising a solution or dispersion of enzyme occluded in filaments of cellulose esters or synthetic polymers |
| DE1933270A1 (de) * | 1968-07-24 | 1970-01-29 | Ceskoslovenska Akademie Ved | Chirurgischer Naehfaden und Verfahren zu dessen Herstellung |
| US3846353A (en) * | 1970-06-08 | 1974-11-05 | Department Of Health Education | Nonthrombogenic plastic material and method for making the same |
| US3688317A (en) * | 1970-08-25 | 1972-09-05 | Sutures Inc | Vascular prosthetic |
| US3932656A (en) * | 1970-09-10 | 1976-01-13 | Alza Corporation | Article of manufacture for instant release of anti-aggregation and non-thrombogenic agents to biological media |
| IT1008202B (it) * | 1974-07-31 | 1976-11-10 | Lostia Onofrio | Fibre inglobanti anticorpi antige ni antisieri procedimento per la loro preparazione e loro impieghi |
| JPS5270587A (en) * | 1974-12-11 | 1977-06-11 | Ethicon Inc | Surgical instrument |
| IT1038741B (it) * | 1975-06-06 | 1979-11-30 | Snam Progetti | Processo per l inglobamento di agenti sequestranti in strutture filamentose agenti seqesttanti inglobati cose ottenuti e loro applicazioni |
| GB1515963A (en) * | 1975-07-15 | 1978-06-28 | Massachusetts Inst Technology | Crosslinked collagen-mucopolysaccharide composite materials |
| GB1556710A (en) * | 1975-09-12 | 1979-11-28 | Anic Spa | Method of occluding substances in structures and products obtained thereby |
| US4073723A (en) * | 1976-11-15 | 1978-02-14 | Swank Roy L | Anti-coagulating and filtering blood |
-
1977
- 1977-03-22 IT IT21482/77A patent/IT1085524B/it active
-
1978
- 1978-03-03 CA CA298,298A patent/CA1095409A/en not_active Expired
- 1978-03-06 AU AU33850/78A patent/AU516197B2/en not_active Expired
- 1978-03-07 IL IL54215A patent/IL54215A/xx unknown
- 1978-03-08 ZA ZA00781362A patent/ZA781362B/xx unknown
- 1978-03-14 DK DK113478A patent/DK113478A/da not_active Application Discontinuation
- 1978-03-14 CH CH277778A patent/CH633712A5/it not_active IP Right Cessation
- 1978-03-15 NO NO780915A patent/NO144008C/no unknown
- 1978-03-15 GB GB10344/78A patent/GB1602163A/en not_active Expired
- 1978-03-17 CS CS781720A patent/CS212269B2/cs unknown
- 1978-03-20 LU LU79273A patent/LU79273A1/xx unknown
- 1978-03-20 DD DD78204305A patent/DD138601A5/de unknown
- 1978-03-20 YU YU00666/78A patent/YU66678A/xx unknown
- 1978-03-20 DE DE2812174A patent/DE2812174C2/de not_active Expired
- 1978-03-21 SE SE7803254A patent/SE436242B/sv unknown
- 1978-03-21 FR FR7808209A patent/FR2395029A1/fr active Granted
- 1978-03-21 HU HU78SA3101A patent/HU179581B/hu unknown
- 1978-03-22 NL NL7803101A patent/NL7803101A/xx not_active Application Discontinuation
- 1978-03-22 JP JP3181278A patent/JPS53117281A/ja active Pending
- 1978-03-22 BE BE186183A patent/BE865192A/xx not_active IP Right Cessation
-
1980
- 1980-09-23 US US06/189,817 patent/US4353996A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU516197B2 (en) | 1981-05-21 |
| LU79273A1 (fr) | 1978-06-29 |
| IL54215A (en) | 1982-02-28 |
| FR2395029A1 (fr) | 1979-01-19 |
| US4353996A (en) | 1982-10-12 |
| IT1085524B (it) | 1985-05-28 |
| NO780915L (no) | 1978-09-25 |
| DE2812174C2 (de) | 1981-10-15 |
| BE865192A (fr) | 1978-09-22 |
| FR2395029B1 (de) | 1982-05-07 |
| DD138601A5 (de) | 1979-11-14 |
| CH633712A5 (it) | 1982-12-31 |
| AU3385078A (en) | 1979-09-13 |
| DK113478A (da) | 1978-09-23 |
| NL7803101A (nl) | 1978-09-26 |
| GB1602163A (en) | 1981-11-11 |
| HU179581B (en) | 1982-11-29 |
| DE2812174A1 (de) | 1978-09-28 |
| SE7803254L (sv) | 1978-10-13 |
| SE436242B (sv) | 1984-11-26 |
| NO144008B (no) | 1981-02-23 |
| ZA781362B (en) | 1979-02-28 |
| CA1095409A (en) | 1981-02-10 |
| JPS53117281A (en) | 1978-10-13 |
| YU66678A (en) | 1984-02-29 |
| NO144008C (no) | 1981-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4353996A (en) | Bio-compatible porous fibres and materials for occluding biologically interesting substances, and method for their manufacture | |
| AU672708B2 (en) | Surface modified biocompatible membranes | |
| EP0466178B1 (de) | Methode und Vorrichtung zur Entfernung von Heparin | |
| DE69932273T2 (de) | Befestigung von Biomolekülen an Oberflächen von medizinischen Geräten | |
| US6756125B2 (en) | Biocompatible medical articles and process for their production | |
| US5342621A (en) | Antithrombogenic surface | |
| US6197289B1 (en) | Removal of biologically active agents | |
| DE68923423T2 (de) | Antithromotisches medizinisches Material, künstliches inneres Organ und Verfahren zur Herstellung eines antithrombotischen medizinischen Materials. | |
| JPH06507558A (ja) | ポリマーコーティング | |
| EP0947205A2 (de) | Verfahren zur Herstellung von biokompatiblen medizinischen Erzeugnissen | |
| DE10004884A1 (de) | Verfahren zum Anbringen von Biomolekülen an Oberflächen mittels funktioneller Amin-Gruppen | |
| US4289756A (en) | Physiological preparation containing loaded cells of expanded volume in suspension, for preferential accumulation in spleen and liver | |
| DE19715504C2 (de) | PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen | |
| EP3297751A1 (de) | Funktionalisierte membrane für biokünstliche organe | |
| DE69734862T2 (de) | Apparat zur Behandlung des Blutes durch extrakorporalen Blutkreislauf, sowie Verfahren zu seiner Herstellung | |
| US4243776A (en) | Preparation of non-thrombogenic polymeric material article with platelet anti-aggregative agent | |
| US6521283B1 (en) | Non-thrombogenic surfaces | |
| EP0580871B1 (de) | Wasserlösliches cellulosederivat und bioverträgliches material | |
| JP3495802B2 (ja) | 医療用材料およびホスホリルコリン基を有するポリビニルアルコール系重合体 | |
| Ito et al. | In vivo and in vitro blood compatibility of polyelectrolyte complexes formed between cellulose derivatives | |
| VON SECESSER et al. | Can protamine be used during perfusion with heparin surface coated equipment? | |
| JPH0144083B2 (de) | ||
| JPH0343424A (ja) | 血液適合性医療用材料 | |
| DD260932A1 (de) | Verfahren zur herstellung von modifizierten celluloseoberflaechen mit verbesserter blutvertraeglichkeit | |
| JPS5951304B2 (ja) | 抗血栓性材料 |